1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 26th May 2025 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice
  4. Forum upgrade planned for Sat/Sun June 7th/8th - Forum will be unavailable for around 1 day. More details.
    Dismiss Notice

CDR-Life Demonstrates Commitment to Differentiated Pipeline with New Autoimmune Candidate CDR111

Discussion in ''Conditions related to ME/CFS' news and research' started by Jaybee00, Jun 2, 2025 at 3:28 PM.

  1. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    2,492
    https://www.businesswire.com/news/h...Pipeline-with-New-Autoimmune-Candidate-CDR111


    CDR111, CDR-Life’s newest clinical candidate, is a trispecific molecule targeting CD19, BCMA and CD3, designed to achieve immune reset through broad B cell depletion. This novel therapeutic approach represents a significant expansion of the company's product portfolio beyond oncology into autoimmune diseases, with potential applications across multiple autoimmune conditions.
     
    Jaybee00, Jun 2, 2025 at 3:28 PM
    #1
    Starlight and Peter Trewhitt like this.

Share This Page